KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $1.2 million.

  • Co-Diagnostics' Total Non-Current Liabilities fell 5642.44% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 5642.44%. This contributed to the annual value of $2.4 million for FY2024, which is 3335.3% down from last year.
  • As of Q3 2025, Co-Diagnostics' Total Non-Current Liabilities stood at $1.2 million, which was down 5642.44% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Total Non-Current Liabilities peaked at $13.0 million during Q4 2021, and registered a low of $554802.0 during Q1 2021.
  • For the 5-year period, Co-Diagnostics' Total Non-Current Liabilities averaged around $4.1 million, with its median value being $3.0 million (2024).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 261259.8% in 2021, then crashed by 7353.2% in 2023.
  • Co-Diagnostics' Total Non-Current Liabilities (Quarter) stood at $13.0 million in 2021, then tumbled by 63.79% to $4.7 million in 2022, then fell by 24.15% to $3.6 million in 2023, then crashed by 33.35% to $2.4 million in 2024, then crashed by 48.58% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.6 million for Q2 2025, and $1.9 million during Q1 2025.